Your session is about to expire
← Back to Search
Healthy Lifestyle Program for Heart Disease Risk Reduction (MBC2 Trial)
N/A
Recruiting
Research Sponsored by Nancy Schoenberg
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Using mobility assistive devices
Cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months (at baseline, 3 months and 9 months)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the MBC2 program, which uses an app, fitness tracker, health coaching, and rewards to improve diet and exercise habits. It targets adults in rural Appalachia, Kentucky who have poor health profiles. The program helps participants track their habits, get personalized advice, and earn rewards for meeting health goals.
Who is the study for?
This trial is for adults living in Appalachian Kentucky who want to improve their health habits. Participants should be willing to use a smartphone app and wear an accelerometer, spend over 90 minutes daily on recreational screen time, eat less than 4.5 cups of fruits/vegetables daily, engage in less than 150 minutes of physical activity weekly, and consume more than 8% of their calories from saturated fat.
What is being tested?
The study tests the 'Adapted MBC2 Program' which includes an app, accelerometer tracking, health coaching sessions, and incentives aimed at increasing fruit/vegetable intake and physical activity while reducing saturated fat consumption and sedentary screen time among participants.
What are the potential side effects?
Since this intervention involves lifestyle changes rather than medication or medical procedures, side effects may include discomfort adjusting to new diet or exercise routines but are not expected to involve typical drug-related adverse reactions.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I use devices to help me move around.
Select...
I have difficulty with memory or thinking clearly.
Select...
I am currently having thoughts about harming myself.
Select...
I am currently taking medication to lose weight.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9 months (at baseline, 3 months and 9 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months (at baseline, 3 months and 9 months)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in diet and activity
Secondary study objectives
Change in Blood Pressure
Change in Body Mass Index (BMI)
Change in Health-Related Quality of Life
+3 moreOther study objectives
Change in HDL-C
Change in LDL-C
Change in plasma glucose
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Adapted MBC2 GroupExperimental Treatment1 Intervention
The Adapted MBC2 Program will utilize a smart phone app, accelerometers, telephone coaching, and behavioral incentives to target fruit and vegetable intake, dietary fat intake, physical activity, and high sedentary leisure screen time. Participants will wear accelerometers, log hours slept, enter real-time information about their relaxation exercises and stress, and monitor goal thermometers to meet targets.
Group II: Stress Management GroupActive Control1 Intervention
The Stress Management Program will utilize a smart phone app, accelerometers, telephone coaching, and behavioral incentives to target stress, relaxation, and sleep. Participants will wear accelerometers, log hours slept, enter real-time information about their relaxation exercises and stress, and monitor 3 goal thermometers (sleep, relaxation, stress) to meet behavioral targets. The Stress Management Program, including the use of the app and assessments, is identical to the Adapted MBC2 program, with the exception of the content.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for health behaviors, such as those in multi-component lifestyle interventions, work through behavioral modification and monitoring. Behavioral modification techniques like cognitive-behavioral therapy (CBT), motivational interviewing, and mindfulness aim to change unhealthy behaviors by altering thought patterns, increasing motivation, and enhancing self-awareness.
Monitoring involves tools like apps, accelerometers, and regular follow-ups to track progress and provide feedback. These mechanisms are crucial as they help identify and modify unhealthy behaviors while offering continuous support and accountability, essential for long-term behavior change and improved health outcomes.
Delineating mechanisms of change in child and adolescent therapy: methodological issues and research recommendations.
Delineating mechanisms of change in child and adolescent therapy: methodological issues and research recommendations.
Find a Location
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,943 Previous Clinical Trials
47,797,583 Total Patients Enrolled
9 Trials studying Health Behaviors
797 Patients Enrolled for Health Behaviors
Nancy SchoenbergLead Sponsor
4 Previous Clinical Trials
3,711 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I use devices to help me move around.I have difficulty with memory or thinking clearly.I am currently having thoughts about harming myself.I am willing to wear a movement tracking device.I am currently taking medication to lose weight.
Research Study Groups:
This trial has the following groups:- Group 1: Stress Management Group
- Group 2: Adapted MBC2 Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.